CN Patent

CN108602847A — 多晶型及方法

Assigned to Galecto Biotech AB · Expires 2018-09-28 · 8y expired

What this patent protects

本发明涉及式(1)的化合物的多晶型物，式(1)为： 该多晶型物特别适用于通过肺部施用来治疗IPF。

USPTO Abstract

本发明涉及式(1)的化合物的多晶型物，式(1)为： 该多晶型物特别适用于通过肺部施用来治疗IPF。

Drugs covered by this patent

Patent Metadata

Patent number
CN108602847A
Jurisdiction
CN
Classification
—
Expires
2018-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Galecto Biotech AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.